Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial

The ATAC trial evaluates in a randomized, double-blind design, Arimidex™ (anastrozole) alone or in combination with tamoxifen, relative to tamoxifen alone as 5-year adjuvant treatment in postmenopausal women with early breast cancer. Patients included in the pharmacokinetic (PK) sub-protocol had bee...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Trialists' Group, The ATAC
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2001
Gaiak:
Regular Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364083/
https://ncbi.nlm.nih.gov/pubmed/11487258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.1925
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak